Despite the positive results from these studies showing correlations between FGF23 levels and either cardiovascular disease or osteoporosis independently, our study did not observe any significant correlations in the same cohort between FGF23, sclerostin, osteoprotegerin, coronary calcification score, and bone mineral density. This evidence concerns the gene FGF23 and osteoporosis.